Director Howard J. Siegel filed a Form 4 with the SEC on November 3, 2026, reporting the sale of 2,000 shares of CME Group Inc. Class A Common Stock on November 2, 2026.

Key Highlights

  • Reporting person: Howard J. Siegel, a director of CME Group Inc. (NASDAQ:CME)
  • Transaction: Sale (transaction code S) of 2,000 shares of Class A Common Stock on November 2, 2026
  • Price: Weighted average price of $303 per share, with individual transactions ranging from $303.00 to $303.08, inclusive
  • Ownership after transaction: 19,873 shares beneficially owned indirectly through a trust following the reported sale
  • Ownership form: Indirect, held by trust
  • Filing signed: By Elizabeth Hensen, as Attorney-in-Fact for Howard J. Siegel, dated November 3, 2026

Details of Howard Siegel's November 2026 CME Group Share Sale

According to the Form 4 filing, Howard J. Siegel, a director of CME Group Inc., disposed of 2,000 shares of CME Group Class A Common Stock on November 2, 2026. The filing identifies the transaction code as "S," indicating a sale. The shares were held and sold indirectly through a trust, and the filing reports that no direct holdings were listed in Table I.

The filing discloses that the price reported is a weighted average of $303 per share. A footnote in the filing states that "these shares were sold in multiple transactions at prices ranging from $303.00 to $303.08, inclusive," and that Siegel "undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote." Following the reported transaction, the filing indicates that Siegel beneficially owns 19,873 shares indirectly through the trust.

No derivative securities transactions were reported in Table II of the filing. The Form 4 was signed by Elizabeth Hensen as Attorney-in-Fact for Howard J. Siegel and filed on November 3, 2026, the date of the earliest transaction being November 2, 2026.

What Was Disclosed

CME Group director Howard J. Siegel reported the sale of 2,000 Class A Common Stock shares on November 2, 2026, at a weighted average price of $303 per share, leaving him with 19,873 shares held indirectly through a trust.